Interestingly, Cereblon/CRBN-deficient T cells resulting in AIOLOS reduced degradation/increased expression, exert a more efficient antigen-specific cytosolic activity against melanoma cells both in vitro and in vivo (Hesterberg et al., 2020). This evidence concerns the gene IKZF3 and melanoma.